Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation

Neuroscience Letters

Volumn 478, Issue 3, 2010, Pages 113-118

  Aid, Saba ^a   Parikh, Nishant ^a   Palumbo, Sara ^a   Bosetti, Francesca ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cyclooxygenase 2; Cytokines; Lipopolysaccharide; Microglia; Neuroinflammation; Neuron

Indexed keywords

CORTICOSTERONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHOLIPASE A2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; PROSTAGLANDIN; PROSTAGLANDIN E; PTGS2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CYTOKINE PRODUCTION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; BLOOD; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; ENCEPHALITIS; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CORTICOSTERONE; CYCLOOXYGENASE 2; ENCEPHALITIS; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; NEUROIMMUNOMODULATION; NEURONS; OXIDATIVE STRESS; PROSTAGLANDINS; PROSTAGLANDINS E; RNA, MESSENGER;

EID: 77953620042     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.076     Document Type: Article

References (41)

1. Aid S., Bosetti F. Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging. Brain Res. Bull. 2007, 73:108-113.
2. Aid S., Langenbach R., Bosetti F. Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. J. Neuroinflamm. [electronic resource] 2008, 5:17.
3. Aid S., Silva A.C., Candelario-Jalil E., Choi S.H., Rosenberg G.A., Bosetti F. Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity. J. Cereb. Blood Flow Metab. 2010, 30:370-380.
4. Andreasson K.I., Savonenko A., Vidensky S., Goellner J.J., Zhang Y., Shaffer A., Kaufmann W.E., Worley P.F., Isakson P., Markowska A.L. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 2001, 21:8198-8209.
5. Breitner J.C., Welsh K.A., Helms M.J., Gaskell P.C., Gau B.A., Roses A.D., Pericak-Vance M.A., Saunders A.M. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 1995, 16:523-530.
6. Candelario-Jalil E. Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences. Pharmacol. Res. 2008, 57:266-273.
7. Choi S.H., Aid S., Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol. Sci. 2009, 30:174-181.
8. Choi S.H., Aid S., Choi U., Bosetti F. Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain. Pharmacogenomics J. 2009.
9. Choi S.H., Langenbach R., Bosetti F. Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J. 2008, 22:1491-1501.
10. Delgado M., Ganea D. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. FASEB J. 2003, 17:1922-1924.
11. Dore S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 2003, 54:155-162.
12. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 1999, 5:698-701.
13. Hayaishi O., Matsumura H. Prostaglandins and sleep. Adv. Neuroimmunol. 1995, 5:211-216.
14. Ho L., Purohit D., Haroutunian V., Luterman J.D., Willis F., Naslund J., Buxbaum J.D., Mohs R.C., Aisen P.S., Pasinetti G.M. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 2001, 58:487-492.
15. Hoozemans J.J., Rozemuller A.J., Janssen I., De Groot C.J., Veerhuis R., Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol. (Berl.) 2001, 101:2-8.
16. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., Ross M.E. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:1294-1299.
17. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2317-2321.
18. Lehnardt S, Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8514-8519.
19. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2001, 2:612-619.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
21. Lleo A., Galea E., Sastre M. Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cell Mol. Life Sci. 2007, 64:1403-1418.
22. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
23. Milatovic D., Zaja-Milatovic S., Montine K.S., Shie F.S., Montine T.J. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo. J. Neuroinflamm. [electronic resource] 2004, 1:20.
24. Minghetti L. Role of COX-2 in inflammatory and degenerative brain diseases. Subcell. Biochem. 2007, 42:127-141.
25. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10954-10959.
26. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 1997, 17:2746-2755.
27. O'Banion M.K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 1999, 13:45-82.
28. Ojeda S.R, Urbanski H.F., Junier M.P., Capdevila J. The role of arachidonic acid and its metabolites in the release of neuropeptides. Ann. N. Y. Acad. Sci. 1989, 559:192-207.
29. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego. G. Paxinos, K.B.J. Franklin (Eds.).
30. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K.A., Kawas C., Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995, 45:51-55.
31. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993, 43:1609-1611.
32. Schmued L.C., Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000, 874:123-130.
33. Spielman L., Winger D., Ho L., Aisen P.S., Shohami E., Pasinetti G.M. Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2. Acta Neuropathol. 2002, 103:157-162.
34. Stefanovic B., Bosetti F., Silva A.C. Modulatory role of cyclooxygenase-2 in cerebrovascular coupling. Neuroimage 2006, 32:23-32.
35. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson-Lewis V., Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5473-5478.
36. Toscano C.D., Ueda Y., Tomita Y.A., Vicini S., Bosetti F. Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice. Brain Res. Bull. 2008, 75:598-609.
37. Vidensky S., Zhang Y., hand T., Goellner J., Shaffer A., Isakson P., Andreasson K. Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response. Neuromol. Med. 2003, 3:15-28.
38. Wang H., Hitron I.M., Iadecola C., Pickel V.M. Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. Cereb Cortex 2005, 15:1250-1260.
39. Wu L., Wang Q., Liang X., Andreasson K. Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci. Lett. 2007, 421:253-258.
40. Xiang Z., Thomas S., Pasinetti G. Increased neuronal injury in transgenic mice with neuronal overexpression of human cyclooxygenase-2 is reversed by hypothermia and rofecoxib treatment. Curr. Neurovasc. Res. 2007, 4:274-279.
41. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993, 11:371-386.